INFLIXIMAB

183871 reported adverse events

Drug classes: Tumor Necrosis Factor Blocker [EPC]

These side effects are most commonly reported by patients taking INFLIXIMAB:

# Side effect Count
0 DRUG INEFFECTIVE 34102
1 OFF LABEL USE 29123
2 INFUSION RELATED REACTION 15397
3 RHEUMATOID ARTHRITIS 15203
4 PAIN 14702
5 CONDITION AGGRAVATED 14506
6 ARTHRALGIA 13623
7 FATIGUE 12638
8 PRODUCT USE ISSUE 11457
9 DRUG INTOLERANCE 9990
See all common reactions for INFLIXIMAB

INFLIXIMAB is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 HUMAN ANTICHIMERIC ANTIBODY POSITIVE 279 0.9269
1 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 3515 0.8794
2 RED BLOOD CELL SEDIMENTATION RATE 219 0.8456
3 SWOLLEN JOINT COUNT INCREASED 956 0.8401
4 PEMPHIGUS 6276 0.7700
5 RHEUMATIC FEVER 1180 0.7697
6 RHEUMATOID FACTOR POSITIVE 2560 0.7171
7 GRANULOMA SKIN 476 0.6620
8 DUODENAL ULCER PERFORATION 2393 0.6503
9 DEEP VEIN THROMBOSIS POSTOPERATIVE 309 0.5931
See all enriched reactions for INFLIXIMAB